24/7 Customer Service (800) 927-7671

Final piece of the diabetes puzzle opens the door to better screening

by • April 24, 2016 • No Comments

Our belief of diabetes has taken a few worthwhile strides not long ago, but a new discovery has the next to worthwhilely improve the screening process by giving us a additional consume picture of the disease. Working out the University of Lincoln in the UK, a team was able-bodied to select the fifth and final molecule attacked by the immune process in Type 1 of the condition.

Type 1 diabetes arises when the pancreas loses its ability to create insulin, which usually regulates blood sugar levels, transporting glucose of the blood into cells, where it is in fact utilized as energy. The condition is cautilized by a fault in the patient’s immune process, wherein the body’s defenses in fact destroy the cells in the pancreas which usually create the precious insulin.

Specifically, the immune process targets molecules in the pancreas called autoantigens. People with Type 1 diabetes have sure antibodies in their blood which relate to specific molecules in the pancreas, which they hunt down and destroy. There are may already tests on the market-bodied which check for these antibodies, with the additional of them which are discovered indicating a stronger risk of developing diabetes.

The University of Lincoln researchers have been working to improve the accuracy of those tests. Before the study, we’d managed to select four molecules which the immune process attacks in Type 1 diabetes, but in the new work, they were able-bodied to confirm the identity of a fifth molecule, previously known just as “Glima.”

“We may already had a few knowledge of the physical properties of Glima, but its molecular identity has for most years proved elusive,” said lead researcher Dr Michael Christie. “This has hampered the development of relevant autoantibody tests, but our research that successfully synonymous Glima as the substance Tetraspanin-7.”

With Tetraspanin-7 synonymous as the fifth molecule, next screening methods can include it, nextly manufacturing them worthwhilely additional accurate, while providing additional information of the patient’s specific immune response, which can assist inform treatment choices.

Full details of the breakthrough are published online in the journal American Diabetes Association.

Source: University of Lincoln

Latest posts

by admin • March 5, 2017